Vectus Biosystems Ltd

ASX:VBS (Australia)  
A$ 0.28 (+14.58%) Apr 19
At Loss
P/B:
6.12
Market Cap:
A$ 14.63M ($ 9.39M)
Enterprise V:
A$ 11.75M ($ 7.54M)
Volume:
2.00K
Avg Vol (2M):
16.42K
Volume:
2.00K
At Loss
Avg Vol (2M):
16.42K

Business Description

Description
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.
Name Current Vs Industry Vs History
Cash-To-Debt 28.84
Equity-to-Asset 0.74
Debt-to-Equity 0.03
Debt-to-EBITDA -0.03
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 15.7
3-Year EPS without NRI Growth Rate 17.2
3-Year FCF Growth Rate 27.4
Name Current Vs Industry Vs History
5-Day RSI 69.81
9-Day RSI 61.03
14-Day RSI 56.18
6-1 Month Momentum % -22.22
12-1 Month Momentum % -51.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.71
Quick Ratio 3.71
Cash Ratio 2.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31
Shareholder Yield % 44.03

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -391200
Net Margin % -248800
FCF Margin % -138200
ROE % -69.58
ROA % -54.53
ROIC % -259.07
ROC (Joel Greenblatt) % -313.26
ROCE % -68.52

Financials

ASX:VBS's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vectus Biosystems Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0.001
EPS (TTM) (A$) -0.044
Beta 1.35
Volatility % 36.33
14-Day RSI 56.18
14-Day ATR (A$) 0.011587
20-Day SMA (A$) 0.2525
12-1 Month Momentum % -51.72
52-Week Range (A$) 0.2 - 0.55
Shares Outstanding (Mil) 53.21

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vectus Biosystems Ltd Filings

Filing Date Document Date Form
No Filing Data

Vectus Biosystems Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Vectus Biosystems Ltd Frequently Asked Questions

What is Vectus Biosystems Ltd(ASX:VBS)'s stock price today?
The current price of ASX:VBS is A$0.28. The 52 week high of ASX:VBS is A$0.55 and 52 week low is A$0.20.
When is next earnings date of Vectus Biosystems Ltd(ASX:VBS)?
The next earnings date of Vectus Biosystems Ltd(ASX:VBS) is .
Does Vectus Biosystems Ltd(ASX:VBS) pay dividends? If so, how much?
Vectus Biosystems Ltd(ASX:VBS) does not pay dividend.

Press Release

Subject Date
No Press Release